Scott J. Leffler serves as the Chief Financial Officer (CFO) at Myriad Genetics Inc., a leading precision medicine company dedicated to advancing health and well-being through innovative genetic testing and research. In his role as CFO, Leffler is responsible for overseeing the financial strategy and operations of the company, ensuring its continued growth and success in the highly competitive field of genetic diagnostics. His leadership has been instrumental in guiding Myriad Genetics through a period of significant expansion and innovation, as the company continues to develop and commercialize groundbreaking genetic tests that improve patient outcomes and advance medical research. Prior to joining Myriad Genetics, Leffler amassed a wealth of experience in financial management and strategic planning across various industries. He held several high-level positions, including CFO roles at notable healthcare and technology firms, where he demonstrated a keen ability to drive financial performance and operational efficiency. Leffler's strategic vision and deep understanding of the financial landscape have been key factors in his success, allowing him to navigate complex market dynamics and position Myriad Genetics as a leader in the field of precision medicine. His commitment to excellence and innovation has not only strengthened the company's financial foundation but also supported its mission to transform healthcare through genetic insights. Under Leffler's guidance, Myriad Genetics has achieved significant milestones, including the successful launch of new genetic testing platforms and the expansion of its global presence. His leadership has been crucial in securing strategic partnerships and investments that have propelled the company forward, enabling it to deliver cutting-edge solutions to patients and healthcare providers worldwide. Leffler's dedication to fostering a culture of financial integrity and transparency has earned him respect and admiration within the industry, solidifying his reputation as a visionary leader in the world of precision medicine.